scispace - formally typeset
J

Johannes Kastner

Researcher at Medical University of Vienna

Publications -  23
Citations -  527

Johannes Kastner is an academic researcher from Medical University of Vienna. The author has contributed to research in topics: Implantable cardioverter-defibrillator & Sudden cardiac death. The author has an hindex of 10, co-authored 23 publications receiving 418 citations.

Papers
More filters
Journal ArticleDOI

Role of NO in the O2 and CO2 responsiveness of cerebral and ocular circulation in humans

TL;DR: The present study supports the concept that NO has a role in hypercapnia-induced vasodilation in humans by studying the effect of NO synthase inhibition by N G-monomethyl-l-arginine on the changes of cerebral and ocular hemodynamic parameters elicited byhypercapnia and hyperoxia in healthy young subjects.
Journal ArticleDOI

Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: Clinical presentation, risk stratification and results of long-term follow-up

TL;DR: In ARVD/C the tachycardia cycle length of clinical VT, PVS-induced VT and follow-up VT correlate well implicating that a PVS -guided approach does not provide additional information.
Journal ArticleDOI

Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease

TL;DR: The presence of SHD has little predictive value for the occurrence or type of arrhythmia in patients with unexplained syncope, and the ILR leads to specific treatment in half of all patients.
Journal ArticleDOI

Evolution of outcome and complications in TAVR: a meta-analysis of observational and randomized studies

TL;DR: TAVR with contemporary next generation devices has led to an impressive improvement in TAVR safety driven by refined case selection, improved procedural techniques and increased site experience.
Journal ArticleDOI

Impact of accelerated ventricular tachyarrhythmias on mortality in patients with implantable cardioverter-defibrillator therapy.

TL;DR: Ventricular ATP with arrhythmia acceleration and subsequent shock delivery is a frequent and serious complication of ICD therapy that predominantly occurs in patients with reduced left ventricular function and was associated with increased all-cause mortality.